Armistice Capital’s Cidara Therapeutics CDTX Stock Holding History

Armistice Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,359	Closed	-$300K	–	294
2025 Q4	$300K	Buy	+1,359	New	+$220K	﹤0.01%	248

Armistice Capital's CDTX Position: Q1 2026 in Review

Armistice Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,359 shares — an estimated $300K sold.

Armistice Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $300K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Armistice Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 1,359 Cidara Therapeutics shares in Q1 2026, an estimated $300K.
Armistice Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Armistice Capital's Cidara Therapeutics position peaked at $300K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.